TrialSpark, which desires to leverage its medical trials administration software program into drug discovery, closed $156M Collection C at a $1B+ valuation earlier this yr (Emma Courtroom/Bloomberg)

0
190

[ad_1]

Emma Courtroom / Bloomberg:

TrialSpark, which desires to leverage its medical trials administration software program into drug discovery, closed $156M Collection C at a $1B+ valuation earlier this yrย  โ€”ย  โ€“ TrialSpark expands from medical trials into growing medicationย  โ€” Firm raised $156 million, is valued at greater than $1 billion


[ad_2]

Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here